Skip to main content
Premium Trial:

Request an Annual Quote

Rubicon Genomics, Beckman Coulter Ink Distribution Agreement for ThruPlex Plasma-seq Kits

NEW YORK (GenomeWeb) – Rubicon Genomics today announced a non-exclusive distribution agreement for its ThruPlex Plasma-seq kits with Beckman Coulter Life Sciences.

Under the terms of the agreement, Beckman Coulter will distribute the kits in the US and Canada. Financial and other details were not disclosed.

The kits prepare next-generation sequencing libraries for whole-genome, whole-exome, and targeted gene sequencing of circulating cell-free DNA in plasma. They are intended for use with Illumina sequencing.

"The explosion in research interest in analyzing cancer mutations using easily accessible plasma samples is making our ThruPLEX Plasma-seq kit one of our most successful product launches to date," Rubicon CEO James Koziarz said in a statement. "The agreement is especially welcome since it expands our existing automation collaboration and allows more researchers access to the technology, including those who are conducting smaller-scale studies and those who require the automated solutions that are essential for large-scale genomics research."

Previously, the two firms have partnered to automate the ThruPlex Plasma-seq kit on the Beckman Coulter Biomek FX Liquid Handling Workstation. The deal is just the latest distribution agreement for Rubicon. Last month, the firm announced distribution deals for India and Poland. Previously, it had signed a European distribution agreement with Eurofins.

Ann Arbor, Michigan-based Rubicon offers library preparation and companion products for research applications.

Beckman Coulter Life Sciences is based in Indianapolis and is a business segment of Danaher's Beckman Coulter subsidiary.